| Translated title of the contribution | Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. |
|---|---|
| Original language | Undefined/Unknown |
| Pages (from-to) | 12-18 |
| Number of pages | 7 |
| Journal | Thorax |
| Volume | 67 |
| Issue number | 1 |
| Publication status | Published - 2012 |
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.
J.P. Clancy, P. Campbell, I. Bronsveld, M. W. Konstan, et al et al
Research output: Contribution to journal › Article › Academic › peer-review